Fingerprint
Dive into the research topics of 'TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo
Hayley Ma, Bao Nguyen, Li Li, Sarah Greenblatt, Allen Williams, Ming Zhao, Mark Levis, Michelle Rudek, Amy Duffield, Donald Small
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations